| Biography | Steven J. Glassman possesses a unique background and combination of experience as a federal prosecutor, patent examiner, trial attorney, and appellate advocate. He received his B.S. from the Massachusetts Institute of Technology (MIT) in 1964. He served as a Patent Examiner in the U.S. Patent and Trademark Office, and was then active in early government-to-industry technology transfer programs with NASA at its Washington, D.C. headquarters. Mr. Glassman then gained extensive trial experience, while serving as an Assistant United States Attorney for the Southern District of New York. He also gained intensive appellate experience as Chief Civil Appellate Attorney in the U.S. Attorney's Office, arguing numerous appeals and supervising the briefing and argument of many other appeals. He has litigated lengthy and complex cases before federal juries and judges in private practice for over 25 years, including securities, commodities, fraud and contract cases, as well as patent and technology cases in the biotechnology, pharmaceutical, chemical, electronics, aeronautics and nuclear energy fields. Many of these litigations have involved products and processes of great strategic and financial importance, as well as multidistrict cases. He routinely handles all aspects of such cases, from pre-complaint investigations, to discovery, trial, and appeal. Mr. Glassman's broad litigation experience has included class action and derivative actions involving alleged foreign payments in the telecommunications industry, alleged manipulation of worldwide commodities markets, fraud, corporate waste and mismanagement. The specific subject matter of patent and technology cases litigated by Mr. Glassman has ranged from cardiovascular and anti-diabetic drug formulations, assays for the detection of hepatitis, medical devices and chemical catalysts, to industrial fibers, aircraft collision avoidance systems, electronic waveform detection systems and computer-controlled manufacturing equipment. He has represented major corporations including Alcoa, AlliedSignal (now Honeywell), AT&T, Chiron, Ciba Vision, GTE, Oppenheimer, Pfizer, Pharmacia & Upjohn, and Union Carbide (now Dow). Mr. Glassman is also experienced in arbitration, provides strategic opinions and counseling, and has advised on corporate acquisitions and public offerings involving intellectual property and other issues. Mr. Glassman has been active as a member of the Association of the Bar, has chaired continuing education and industry programs, and has written and lectured on a variety of matters, including jury trials, working with experts in litigation, reliance on advice of counsel, and advantages of litigation versus arbitration. Government Service Assistant U.S. Attorney, Southern District of New York, 1971-76 Chief, Civil Rights Section, U.S. Attorney's Office,1974-75 Chief Civil Appellate Attorney, S.D.N.Y., 1975-76 Assistant Section Chief and Counsel, Technology Utilization, National Aeronautics and Space Administration, 1966-71 Patent Examiner, U.S. Patent Office, 1964-65 News September 23, 2009, Green Technology Patents and Litigation September 16, 2009, "Green Technology Patent Litigation: The Future is Here," PLI Green Webcast July 30, 2008, "Litigating Green Technology Patent Cases," Celesq Law Technology Series Publications September 30, 2009, U.S. Court of Appeals Upholds Suits to Abate Contributions to Global Warming that Constitute a Public Nuisance May 18, 2007, "Microsoft v. AT&T, Patented Noncomputer Technology," New York Law Journal March 8, 2005, "Strategies after Knorr-Bremse," IP Law Bulletin 2005, "Hatch-Waxman Litigation from the Perspective of Pioneer Pharmaceutical Companies," ABA Patent Litigation Strategies Handbook, 2d Ed. 2005; Cumulative Supplements 2007, 2008, 2009 October 29, 2001, "Many Factors in Mix at Patent Jury Trials," New York Law Journal March 1997, "Patent Litigation and Prosecution After the Supreme Court's Hilton-Davis Decision," The Journal of Proprietary Rights October 1996, "Why Patent Disputes Should Generally Be Litigated, Not Arbitrated," Corporate Counsel Spring 1996, "Are Companies Immune From Patent Litigation While They Are Still Awaiting FDA Approval?" Intellectual Property Worldwide Outlook June 1996, "Litigating the Scope of U.S. Patents: The Supreme Court's Next Target," Corporate Counsel 1996, "Reliance on Advice of Counsel in Patent Litigation," Managing Intellectual Property Patent Yearbook Media May 18, 2007, Steven Glassman Authors Article on Implications of U.S. Supreme Court's Microsoft v. AT&T Decision |